2017 Publications

By http://www.midatlanticretina.com/author
December 21, 2017

Devon H. Ghodasram, Allen C. Ho, K. Thiran Jayasundera, David N. Zacks. Retinal Prostheses: Clinical Outcomes and Potential Complications. Essentials in Ophthalmology 2017.

 

Allen C. Ho, Namrata Saroj, Keith Baker, Robert Vitti, Alyson J. Berliner, Desmond Thompson, Daniel B. Roth.  Impact of Baseline Characteristics on Treatment Response to Intravitreal Aflibercept Injection for Wet Age-Related Macular Degeneration. Ophthalmology Retina 2017.


Khan MA, Kuley A, Riemann CD, Berrocal MH, Lakhanpal RR, Hsu J, Sivalingam A, Ho AC, Regillo CDLong-term visual outcomes and safety profile of 27-gauge pars plana vitrectomy for posterior segment disease. Ophthalmology 2017 [Epub ahead of print Nov 13]

 

Ho AC, Chang TS, Samuel M, Williamson P, Willenbucher RF, Malone T. Experience With a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration. Am J Ophthalmol. 2017 Jul;179:67-80.

 

Garg SJ.  Panelist. Injection Technique Update.  Retinal Physician.  June 2017, 3-12.


Yaspan BL, Williams DF, Holz FG, Regillo CD, Li Z, Dressen A, van Lookeren Campagne M, Le KN, Graham RR, Beres T, Bhangale TR, Honigberg LA, Smith A, Henry EC, Ho C, Strauss EC; MAHALO Study Investigators.  Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration. Sci Transl Med 2017 Jun 21 [Epub ahead of print]

 

DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD. Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular Degeneration: A Prospective Clinical Trial. Am J Ophthalmol 2017 Jun 15. [Epub ahead of print]


Regillo CD, Callanan DG, Do DV, Fine HF, Holekamp NM, Kuppermann BD, Singer MA, Singh RP.  Use of corticosteroids in the treatment of patients with diabetic macular edema who have suboptimal response to anti-VEGF:  Recommendations of an expert panel. Ophthalmic Surg Lasers Imaging Retina 2017;48:291-301.


Wittenborn JS, Clemons T, Regillo C, Rayess N, Liffmann Kruger D, Rein D.  Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System. JAMA Ophthalmol 2017;135:452-459.

 

Rahimy E, Pitcher JD 3rd, Hsu J, Adam MK, Shahlaee A, Samara WA, Vander JF, Kaiser RS, Chiang A, Spirn MJ, Fineman MS. A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ECSELSIOR). Retina 2017 Apr 19. doi: 10.1097/IAE.0000000000001649. (Epub ahead of print)
Sridhar J, Kasi S, Paul J, Shahlaee A, Rahimy E, Chiang A, Spirn MJ, Hsu J, Garg SJ. A prospective, randomized trial comparing plain gut to polyglactin 910 (Vicryl) sutures for sclerotomy closure after 23-gauge pars plana vitrectomy. Retina 2017 May 10. doi: 10.1097/IAE.0000000000001684. (Epub ahead of print)


Garg SJ. Interviewee. Recognizing the Signs for When Not to Operate.  Delaying, referring, or canceling a surgery can sometimes be the best choice.  Retinal Physician.  May 2017.


Khan MA, Samara WA, Gerstenblith AT, Chiang A, Mehta S, Garg SJ, Hsu J, Gupta OPCombined pars plana vitrectomy and scleral fixation of an intraocular lens using Gore-Tex suture: one-year outcomes. Retina 2017 May 10. doi:10.1097/IAE.0000000000001692. (Epub ahead of print)


Garg SJ. Autoimmune Thyroid Disease and Uveitis. JAMA Ophthalmol. 2017 May 4. doi: 10.1001/jamaophthalmol.2017.0776. [Epub ahead of print]


Thomas BJ, Mehta N, Yonekawa Y, Sridhar J, Kuriyan AE, Rehlan N, Liang MC, Woodward MA, Witkin AJ, Shah C, Flynn HW Jr, Garg SJ, Wolfe JD.  Pars plana vitrectomy for late vitreoretinal sequelae of infectious endophthalmitis: Surgical management and outcomes. Retina. 2017 Apr;37(4):651-656

 

Sridhar J, Yonekawa Y, Kuriyan AE, Joseph A, Thomas BJ, Liang MC, Rayess N, Relhan N, Wolfe JD, Shah CP, Witkin AJ, Flynn HW Jr, Garg SJMicrobiologic spectrum and visual outcomes of acute onset endophthalmitis undergoing therapeutic pars plana vitrectomy. Retina 2016 Oct 21 (Epub ahead of print)


Joshi N, Adam M, Garg SJ. Central serous chorioretinopathy. EyeWiki.  April 2017.


Samara WA1, Shahlaee A1, Adam MK1, Khan MA1, Chiang A1, Maguire JI1, Hsu J1, Ho AC2. Quantification of Diabetic Macular Ischemia Using Optical Coherence Tomography Angiography and Its Relationship with Visual Acuity. Ophthalmology. 2017 Feb;124(2):235-244. doi: 10.1016/j.ophtha.2016.10.008. Epub 2016 Nov 23.


Wittenborn JS, Clemons T, Regillo C, Rayess N, Liffmann Kruger D, Rein D.  Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System. JAMA Ophthalmol 2017 Mar 30 [Epub ahead of print]


Khan MA, Durrani AK, Hsu J, Regillo CD27-gauge vitrectomy wound integrity: A Randomized Pilot Study Comparing Angled Versus Straight Entry in Fluid-Filled Vitrectomized Eyes. Retina 2017 Mar 29 [Epub ahead of print]


Rahimy E, Rayess N, Brady CJ, Regillo CDTreat-and-extend regimen for macular edema secondary to central retinal vein occlusion:  12 month results. Ophthalmology Retina 2017;1:118-123.


Ho AC, Albini TA, Brown DM, Boyer DS, Regillo CD, Heier JS.  The Potential Importance of Detection of Neovascular Age-Related Macular Degeneration When Visual Acuity Is Relatively Good. JAMA Ophthalmol. 2017 Mar 1;135(3):268-273

 

DeCroos FC, Reed D, Adam MK, Salz D, Gupta OP, Ho AC, Regillo CD. Treat-and-Extend Therapy Using Aflibercept for Neovascular Age-related Macular  Degeneration: A Prospective Clinical Trial. Am J Ophthalmol 2017;180:142-150.

 

Aderman C, Garg SJ. Intravitreal anti-VEGF injection treatment algorithms for DMERetina Today.  July/August 2017, 53-55.

 

Garg SJ (Faculty).  Injection Techinque Update. Retinal Physician.  June 2017, 3-12.


Regillo CD, Callanan DG, Do DV, Fine HF, Holekamp NM, Kuppermann BD, Singer MA, Singh RP.  Use of corticosteroids in the treatment of patients with diabetic macular edema who have suboptimal response to anti-VEGF:  Recommendations of an expert panel. Ophthalmic Surg Lasers Imaging Retina 2017;48:291-301.

 

Garg SJ. Outcomes of ocriplasmin for symptomatic VMA. Interviewer, Academy Express.  September 20, 2017. https://www.aao.org/interview/outcomes-of-ocriplasmin-symptomatic-vma

 

Garg SJ. Vitrectomy with subretinal tPA for thick submacular hemorrhage. Retinal Physician.  September 2017, 23-24.

 

Wittenborn JS, Clemons T, Regillo C, Rayess N, Liffmann Kruger D, Rein D.  Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.  JAMA Ophthalmol 2017;135:452-459.

Garg SJ (interviewee)Learning in the OR. Retina Today.  September 2017, 22-24.

 

Ho AC, Chang TS, Samuel M, Williamson P, Willenbucher RF, Malone T. ExperienceWith a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration. Am J Ophthalmol. 2017 Jul;179:67-80. doi: 10.1016/j.ajo.2017.04.006. PubMed PMID: 28435054.

 

Adam MK, Shahlaee A, Samara WA, Maguire JI, Ho AC, Hsu J. EN FACE VERSUS 12-LINE RADIAL OPTICAL COHERENCE TOMOGRAPHY SCAN PATTERNS FOR DETECTION OF MACULAR FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina Cases Brief Rep. 2017 Aug 14. doi: 10.1097/ICB.0000000000000616. [Epub ahead of print] PubMed PMID: 28816861.

McKeague M, Sharma P, Ho AC. Evaluation of the macula prior to cataract surgery. Curr Opin Ophthalmol. 2017 Sep 11. doi: 10.1097/ICU.0000000000000432. [Epub ahead of print] PubMed PMID: 28902720.

 

Jenkins TL, Adam MK, Hsu J. Intraoperative Optical Coherence Tomography of Internal Limiting Membrane Flap. Ophthalmology. 2017 Oct;124(10):1456. (Senior author)

Joshi N, Adam M, Samara W, Shahlaee A, Rahimy E, Aderman C, Hsu J, Fineman M, Garg SJ. Optical density of subretinal fluid as a predictive biomarker for eyes with chronic central serous retinopathy treated with epleronone. Journal of Vitreoretinal Diseases. Epub ahead of print. https://doi.org/10.1177/2474126417746462

 

 

 

 


 

 

Category:


Comments are closed.